> Sorry for asking out of context question. Can a mutated DNA or protein
> molecule be patented.
Yes and no. A molecule as such cannot be patented. But the use of a molecule
for a specific purpose can be. There are many patents for small molecule drugs,
and also for engineered antibodies, which
Hi.
A mutated DNA or protein molecule can be patented if the mutations are not
present in nature and they have a technical effect (for example, in the
case of antibodies, you could have increased affinity for an antigen if you
make the right mutations of the CDRs). Also, the mutations should not h
Realistically, if you live in the US and 5 SCOTUS judges agree you can
patent anything.
On Fri, Nov 3, 2017 at 09:45 Francisco Tenjo wrote:
> Hi.
>
> A mutated DNA or protein molecule can be patented if the mutations are not
> present in nature and they have a technical effect (for example, in t
A related question. If you have a crystal structure and found a novel
ligand binding site that can be used to regulate protein activity, could
you patent such "binding site"? If not, how to make the best use of such
findings?
Thanks!
Cheng
On Sat, Nov 4, 2017 at 12:33 AM, James Phillips
wrote:
You cannot patent the “binding site” because it is found in nature (you did
not invent it, you discovered it and patents are only granted for
inventions). I think you could patent compounds that bind that site if they
are not the exact natural ligands.
- Francisco
On Fri, Nov 3, 2017 at 9:14 PM C
I second Gert's thoughts
Best,
Abhishek
On Sat, Nov 4, 2017 at 10:21 AM, Gert Vriend
wrote:
> A related question. If you have a crystal structure and found a novel
>> ligand binding site that can be used to regulate protein activity, could
>> you patent such "binding site"? If not, how to m
On Behalf Of Abhishek
Anan
Sent: Saturday, November 4, 2017 05:31
To: CCP4BB@JISCMAIL.AC.UK
Subject: Re: [ccp4bb] Regarding Patents
I second Gert's thoughts
Best,
Abhishek
On Sat, Nov 4, 2017 at 10:21 AM, Gert Vriend mailto:gerrit.vri...@radboudumc.nl> > wrote:
A related qu
>
> a reasonable proposition….
>
>
>
> Best, BR
>
>
>
> *From:* CCP4 bulletin board [mailto:CCP4BB@JISCMAIL.AC.UK] *On Behalf Of
> *Abhishek
> Anan
> *Sent:* Saturday, November 4, 2017 05:31
> *To:* CCP4BB@JISCMAIL.AC.UK
> *Subject:* Re: [ccp4bb] Regarding Patents
Of *Abhishek Anan
*Sent:* Saturday, November 4, 2017 05:31
*To:* CCP4BB@JISCMAIL.AC.UK <mailto:CCP4BB@JISCMAIL.AC.UK>
*Subject:* Re: [ccp4bb] Regarding Patents
I second Gert's thoughts
Best,
Abhishek
On Sat, Nov 4, 2017 at 10:21 AM, Gert Vriend
CP4BB@JISCMAIL.AC.UK] on behalf of Alun R Coker
[alun.co...@ucl.ac.uk]
Sent: 05 November 2017 20:35
To: CCP4BB@JISCMAIL.AC.UK
Subject: Re: [ccp4bb] Regarding Patents
In the UK many Universities policies lay claim to IPR as belonging to the
university, rather than the academic (this is based on U
34 AM
To: CCP4BB@JISCMAIL.AC.UK
Subject: Re: [ccp4bb] Regarding Patents
Dear all,
one of the most interesting documents in recent times on the matter of
translational research and IP comes from the Wellcome Trust:
https://wellcome.ac.uk/sites/default/files/transforming-uk-translation-20170
72
AIL.AC.UK>
Subject: Re: [ccp4bb] Regarding Patents
I second Gert's thoughts
Best,
Abhishek
On Sat, Nov 4, 2017 at 10:21 AM, Gert Vriend
mailto:gerrit.vri...@radboudumc.nl>> wrote:
A related question. If you have a crystal structure and found a novel ligand
binding site that
12 matches
Mail list logo
